Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (361-370 of 448) with videos related to

Pageof 45
Sort By:
Clinical and Experimental Rheumatology|July 1, 2017
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosisPatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Plos One|May 7, 2013
Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysisEmmanuelle Génin, Baptiste Coustet, Yannick Allanore, et al.
Seminars in Arthritis and Rheumatism|September 11, 2023
The phenotype of mixed connective tissue disease patients having associated interstitial lung diseaseGonçalo Boleto, Silje Reiseter, Anna-Maria Hoffmann-Vold, et al.
RMD Open|August 4, 2023
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohortElisabetta Zanatta, Elisabetta Cocconcelli, Gioele Castelli, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|January 18, 2015
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR populationEric Hachulla, Pierre Clerson, Paolo Airò, et al.
Pageof 45

Showing results (361-370 of 448) with videos related to

Sort By:
Pageof 45
Clinical and Experimental Rheumatology|July 1, 2017
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosisPatricia E Carreira, Loreto Carmona, Beatriz E Joven, et al.
Annals of the Rheumatic Diseases|October 25, 2014
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective studyMuriel Elhai, Jérôme Avouac, Ulrich A Walker, et al.
Annals of the Rheumatic Diseases|October 26, 2017
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)Dinesh Khanna, Christopher P Denton, Celia J F Lin, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Plos One|May 7, 2013
Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysisEmmanuelle Génin, Baptiste Coustet, Yannick Allanore, et al.
Seminars in Arthritis and Rheumatism|September 11, 2023
The phenotype of mixed connective tissue disease patients having associated interstitial lung diseaseGonçalo Boleto, Silje Reiseter, Anna-Maria Hoffmann-Vold, et al.
RMD Open|August 4, 2023
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohortElisabetta Zanatta, Elisabetta Cocconcelli, Gioele Castelli, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Annals of the Rheumatic Diseases|September 14, 2016
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity indexGabriele Valentini, Michele Iudici, Ulrich A Walker, et al.
Rheumatology (Oxford, England)|January 18, 2015
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR populationEric Hachulla, Pierre Clerson, Paolo Airò, et al.
Pageof 45